The U.S. Food and Drug Administration has approved the antibiotic Zevtera (ceftobiprole medocaril sodium for injection) for three different indications, including treatment of adults with Staphylococcus aureus bloodstream ...
Apr 9, 2024
0
1
In patients with device-detected atrial fibrillation and a high comorbidity burden, oral anticoagulation increases bleeding without a clear reduction in stroke. This is the main finding of a sub-analysis of the NOAH–AFNET ...
Apr 9, 2024
0
1
A new comprehensive review, authored by the International Osteoporosis Foundation (IOF) Committee of Scientific Advisors Fracture Working Group on behalf of the IOF and the International Society of Orthopaedic Surgery and ...
Apr 8, 2024
0
1
People with diabetes who had suffered a heart attack derived no clinical benefit from edetate disodium-based chelation, a therapy that draws lead and other toxic metals linked to increased risk of heart disease and stroke ...
Apr 8, 2024
0
0
For patients with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma, cadonilimab plus chemotherapy is associated with improved overall survival and progression-free survival, according to a study presented at the annual ...
Apr 8, 2024
0
0
Using a web application to qualify individuals for treatment with a non-prescription statin closely matched the results of clinician assessments in determining a person's eligibility for taking statins to lower cholesterol, ...
Apr 8, 2024
0
0
Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery topically rather than intravenously did not meet its primary endpoint of reducing seizures and was stopped early due to an increased ...
Apr 8, 2024
0
0
For patients with acute myocardial infarction at risk for heart failure, empagliflozin reduces the risk for heart failure hospitalization, according to a study published online April 6 in Circulation to coincide with the ...
Apr 8, 2024
0
0
Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or "bad" cholesterol, levels ...
Apr 8, 2024
0
0
In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing ...
Apr 8, 2024
0
0
